1. Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) - does it leverage any advantage in clinical decision making?;Florkowski;Crit. Rev. Clin. Lab. Sci.,2017
2. Regulation (EU), 2017/746 of the European Parliament and of the Council of 5 April 2017 on in Vitro Diagnostic Medical Devices and Repealing Directive 98/79/EC L117: 2017 and Commission Decision 2010/227/EU.Official J Eur Union 176 332.
3. Implementation of point-of-care testing in a pediatric healthcare setting;Patel;Crit. Rev. Clin. Lab. Sci.,2019
4. Belgian Healthcare Knowledge Center. KCE Repport 311: proposals for a more effective antibiotic policy in Belgium. Available at: https://kce.fgov.be/nl/publicaties/alle-rapporten/voorstellen-voor-een-effectiever-antibioticabeleid-in-belgie2019 (Accessed December 26th 2023).
5. Harrington P, Lucey D, O'Brien K, Jordan K, Moran P, Marschall L. C-reactive prooien point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections (RTIs). Rapid assessment on other health technologies using the HTA core model for rapid relative effectiveness assessment. EUnetHTA Project ID: OTCA012. Available at: https://www.eunethta.eu/wp-content/uploads/2019/02/EUnetHTA_OTCA012_CRP-POCT_31012019.pdf2019 (Accessed December 26th 2023).